Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹-1,245 Cr₹-1,066 Cr₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-1,245 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹-1,245 Cr
Mar2025₹-1,066 Cr
Mar2024₹-1,049 Cr
Mar2023₹-1,805 Cr
Mar2022₹-1,655 Cr

How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹-1,245 Cr
Negative
Mar2025 ₹-1,066 Cr
Negative
Mar2024 ₹-1,049 Cr
Negative
Mar2023 ₹-1,805 Cr
Negative
Mar2022 ₹-1,655 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,636.1 Cr -1.7% 0.6% 12.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,394.0 Cr -2.3% -3.3% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,312.0 Cr 0.3% 16.3% 44.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,678.0 Cr 2.8% -0.5% 37.1% Stock Analytics
CIPLA ₹114,392.0 Cr -3.1% -1.2% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,740.5 Cr -2.9% -3% -3.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.7%

0.6%

12.2%

SENSEX

-1.4%

-1%

-4.6%


You may also like the below Video Courses